Invivyd initiates new pipeline discovery programme focused on monoclonal antibody treatment for measles: Waltham, Massachusetts Tuesday, May 13, 2025, 16:00 Hrs [IST] Invivyd, Inc ...

Multiple HCPs have requested from Invivyd a monoclonal antibody (mAb) for treatment of active measles infection and post-exposure prophylaxis to reduce the consequence of outbreaks. Such a medicine ...

The scope of the presented studies is somewhat limited, as they primarily focus on evaluating the phenotypic changes in cardiac innervation following the loss of various Slit or Robo genes.